Literature DB >> 3263085

Effects of cigarette smoking on blood levels of leukotrienes and plasma levels of complements C3a and C5a in healthy volunteers.

J Kobayashi1, Y Kihira, S Kitamura.   

Abstract

We reported previously that cigarette smoking induces bronchoconstriction. In the present investigation we measured the level of peripheral venous blood leukotrienes, which are known to cause marked bronchoconstriction, and plasma complement C3a and C5a, which are known to have chemotactic and anaphylatoxic activities. All of these showed a significant increase after cigarette smoking. These data may suggest that the activation of complement induces the release of leukotrienes, and that these leukotrienes cause bronchoconstriction. It appears likely, therefore, that cigarette smoking induces an increase in peripheral venous blood leukotrienes and complement C3a and C5a, and that such an increase may elicit bronchoconstriction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263085     DOI: 10.1080/00039896.1988.9934951

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  5 in total

Review 1.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review.

Authors:  H van der Vaart; D S Postma; W Timens; N H T ten Hacken
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

2.  Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial.

Authors:  Jason E Lang; Allen J Dozor; Janet T Holbrook; Edward Mougey; Sankaran Krishnan; Shawn Sweeten; Robert A Wise; W Gerald Teague; Christine Y Wei; David Shade; John J Lima
Journal:  J Allergy Clin Immunol Pract       Date:  2013-01-12

Review 3.  Airway inflammation and hypersensitivity induced by chronic smoking.

Authors:  Yu Ru Kou; Kevin Kwong; Lu-Yuan Lee
Journal:  Respir Physiol Neurobiol       Date:  2011-03-10       Impact factor: 1.931

4.  Smoking cessation and nicotine substitution modulate eicosanoid synthesis ex vivo in man.

Authors:  A Riutta; V Saareks; I Mucha; J Alanko; M Parviainen; H Vapaatalo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

5.  Complement system biomarkers in first episode psychosis.

Authors:  Maja Kopczynska; Wioleta Zelek; Samuel Touchard; Fiona Gaughran; Marta Di Forti; Valeria Mondelli; Robin Murray; Michael C O'Donovan; B Paul Morgan
Journal:  Schizophr Res       Date:  2017-12-24       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.